Viewing nowCombinationJardiance Duo Tablet 12.5/1000 mg (Empagliflozin, Metformin)
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 202302786 · Approved 2023.09.20 · Insurance code 657808050
Improves glycemic control in adults with type 2 diabetes mellitus
This medication works by combining empagliflozin and metformin to effectively enhance blood sugar control in patients with type 2 diabetes in conjunction with diet and exercise. It is particularly suitable for adult patients with type 2 diabetes whose blood sugar control is insufficient and may also be considered for patients with cardiovascular disease. However, caution regarding the occurrence of cardiovascular events should be detailed in clinical trial information for professionals. This medication supports the management of patients' health by improving blood sugar control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's existing metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their existing doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients 75 years of age or older, renal function and the risk of volume depletion should be taken into consideration.
This medication can cause severe lactic acidosis, which is very rare but can be fatal, so caution is advised. Symptoms of hypoglycemia may occur when used with other diabetes medications, so caution is necessary. Patients with moderate to severe renal impairment or acute kidney issues should not use this medication. Patients in serious conditions such as acute infections, heart disease, or sepsis should also avoid administration. It is not suitable for patients with type 1 diabetes or a history of ketoacidosis. Before and after tests using radiographic contrast agents, renal function should be checked, and the medication should be discontinued if necessary. Patients scheduled for surgery should stop taking this medication 48 hours prior to surgery and resume afterward. Patients with liver dysfunction, severe lung disease, excessive alcohol intake, or dehydration symptoms should also be cautious. Women who are pregnant or breastfeeding should not take this medication. Elderly patients are at higher risk of fluid loss, requiring increased caution when taking this medication and regular monitoring of renal function. This medication may cause side effects such as hypoglycemia, urinary tract infections, genital infections, and increased urination, so if symptoms appear, patients should consult healthcare professionals immediately. Regular blood tests are recommended as vitamin B12 levels may decrease. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid it during treatment. Patients are particularly advised to be cautious of irregular meals, excessive exercise, and taking other medications during treatment. Since there may be a possibility of drug interactions, patients should inform healthcare professionals of any other medications they are taking. This medication is not recommended for children and adolescents under 18 years old, as its safety and efficacy have not been established. In the case of overdose, patients should immediately visit a medical institution for appropriate treatment, and dialysis may be required. This medication should be stored out of reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent contact with air or moisture. Additionally, it is best to store the medication at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication for a longer period.
Biconvex, oval-shaped, film-coated tablet with a dark brownish-purple color
60 tablets/bottle [10 tablets/PTP x 6], 30 tablets/bottle, 10 tablets/box [10 tablets/PTP x 1], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.